These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34530694)

  • 1. Management of inflammatory bowel disease during the COVID-19 pandemic.
    Hisamatsu T
    Immunol Med; 2022 Sep; 45(3):128-135. PubMed ID: 34530694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
    El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F
    Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement].
    Park YE; Lee YJ; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Kim SE; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):105-116. PubMed ID: 34446633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce.
    Magro F; Rahier JF; Abreu C; MacMahon E; Hart A; van der Woude CJ; Gordon H; Adamina M; Viget N; Vavricka S; Kucharzik T; Leone S; Siegmund B; Danese S; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S798-S806. PubMed ID: 32722754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
    Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
    World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
    Mossa M; Neri B; Montesano L; Salvatori S; Marafini I; Scucchi L; Lolli E; Massoud R; Petruzziello C; Bernardini S; Calabrese E; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3787-3796. PubMed ID: 35647861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel disease].
    Tóbi L; Prehoda B; Balogh A; Dezsőfi-Gottl A; Cseh Á
    Orv Hetil; 2022 Feb; 163(6):214-221. PubMed ID: 35124570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of biologics in inflammatory bowel disease patients with COVID-19.
    Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
    Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
    Dotan I; Panaccione R; Kaplan GG; O'Morain C; Lindsay JO; Abreu MT
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S785-S790. PubMed ID: 32959882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.
    Kumric M; Ticinovic Kurir T; Martinovic D; Zivkovic PM; Bozic J
    World J Gastroenterol; 2021 Jul; 27(25):3748-3761. PubMed ID: 34321841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients' behavior.
    Dorfman L; Nassar R; Binjamin Ohana D; Oseran I; Matar M; Shamir R; Assa A
    Pediatr Res; 2021 Sep; 90(3):637-641. PubMed ID: 33446913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    Allez M; Fleshner P; Gearry R; Lakatos PL; Rubin DT
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S774-S779. PubMed ID: 32722757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
    Wang H; Tu L; Li Y; Bai T; Zou K; Xiao F; Li J; Chen M; Zhang H; Li G; Lu Y; Wang K; Jin S; Yang Y; Zhu L; Hou X
    J Immunol Res; 2020; 2020():2847316. PubMed ID: 33062719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management.
    M'Koma AE
    Med Res Arch; 2023 Jan; 11(1):. PubMed ID: 37089816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).
    Nakase H; Hayashi Y; Hirayama D; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Abukawa D; Hisamatsu T;
    J Gastroenterol; 2022 Mar; 57(3):174-184. PubMed ID: 35089397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.